mifepristone has been researched along with Choriocarcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, T; Huang, Z; Hyodo, H; Kawana, K; Kozuma, S; Matsumoto, J; Nagamatsu, T; Taketani, Y; Yamashita, T; Yasugi, T | 1 |
| Li, GM; Li, LH; Librach, CL; Xiao, R; Yie, SM | 1 |
| Librach, CL; Xiao, R; Yie, SM | 1 |
| Mark, PJ; Waddell, BJ | 1 |
| Lee, EW; Leung, PC; Mao, Q; Ross, DD; Unadkat, JD; Wang, H; Zhou, L | 1 |
| Chi, CW; Ho, CK; Wang, SY; Yu, KJ | 1 |
| Sun, L; Wang, C; Zheng, Y | 1 |
7 other study(ies) available for mifepristone and Choriocarcinoma
| Article | Year |
|---|---|
Effect of progesterone on HLA-E gene expression in JEG-3 choriocarcinoma cell line.
Topics: Cell Line, Tumor; Choriocarcinoma; Gene Expression; Gene Expression Regulation; Histocompatibility Antigens Class I; HLA Antigens; HLA-E Antigens; Humans; Mifepristone; Progesterone; Receptors, Progesterone; RNA, Messenger; Trophoblasts; Up-Regulation | 2009 |
Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro.
Topics: Cells, Cultured; Choriocarcinoma; Female; Gene Expression; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; RNA, Messenger; Trophoblasts; Up-Regulation | 2006 |
Progesterone regulates HLA-G gene expression through a novel progesterone response element.
Topics: Breast Neoplasms; Cell Line; Cell Line, Tumor; Choriocarcinoma; DNA Primers; Female; Gene Expression Regulation; Genes, Reporter; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Humans; Mifepristone; Pregnancy; Progesterone; Promoter Regions, Genetic; Receptors, Progesterone; Uterine Neoplasms | 2006 |
P-glycoprotein restricts access of cortisol and dexamethasone to the glucocorticoid receptor in placental BeWo cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line, Tumor; Choriocarcinoma; Cyclosporine; Dexamethasone; Female; Humans; Hydrocortisone; Mifepristone; Receptors, Glucocorticoid | 2006 |
Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Choriocarcinoma; Dose-Response Relationship, Drug; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Luciferases; Mifepristone; Mutation; Neoplasm Proteins; Placenta; Pregnancy; Progesterone; Promoter Regions, Genetic; Protein Isoforms; Receptors, Progesterone; Response Elements; Statistics as Topic; Transcription, Genetic; Transfection; Uterine Neoplasms | 2008 |
Tamoxifen-mediated anti-cellular effect against a choriocarcinoma cell line.
Topics: Cell Line; Cell Survival; Choriocarcinoma; Estrogen Antagonists; Female; Hormone Antagonists; Humans; Kinetics; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Trophoblasts; Uterine Neoplasms | 1998 |
[Effects of mifepristone on choriocarcinoma cell line JAR in vitro].
Topics: Cell Division; Choriocarcinoma; Chorionic Gonadotropin; Female; Humans; Ki-67 Antigen; Mifepristone; Pregnancy; Tumor Cells, Cultured; Uterine Neoplasms | 1999 |